Vendor, San Francisco, CA
Vivid Bioinnovations, PBC
UEI Q1NZN4P95F83, CAGE 8BMG6
1 award and $595,337 obligated between August 28, 2025 and August 28, 2025, 100% under full and open competition, against 12.0 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $595,337 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93025C00029Definitive Contract, August 28, 2025, Full and Open Competition After Exclusion of Sources, 12 offersSolicitation | National Institutes of Health NiaidNational Institutes of Health | Multiplexed Nucleic Acid Self-Test for Reproducible and Sensitive Hiv DetectionNAICS 541715, PSC AN12 | $595,337 |
- Places of performance
- California
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards